Mercer Global Advisors Inc Moderna, Inc. Transaction History

Mercer Global Advisors Inc

  • $48.3 Billion
  • Q2 2025

A detailed history of Mercer Global Advisors Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 7,573 shares of MRNA stock, worth $188,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,573
Previous 7,765 2.47%
Holding current value
$188,643
Previous $220,000 5.45%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$23.65 - $28.54 $4,540 - $5,479
-192 Reduced 2.47%
7,573 $208,000
Q1 2025

May 15, 2025
BUY
$28.35 - $47.53 $10,517 - $17,633
371 Added 5.02%
7,765 $220,000
Q4 2024

Feb 14, 2025
SELL
$36.85 - $63.93 $266,867 - $462,981
-7,242 Reduced 49.48%
7,394 $307,000
Q3 2024

Nov 13, 2024
SELL
$63.64 - $125.14 $537,248 - $1.06 Million
-8,442 Reduced 36.58%
14,636 $978,000
Q2 2024

Aug 12, 2024
SELL
$101.21 - $166.61 $203,938 - $335,719
-2,015 Reduced 8.03%
23,078 $2.74 Million
Q1 2024

May 15, 2024
SELL
$85.37 - $115.44 $957,936 - $1.3 Million
-11,221 Reduced 30.9%
25,093 $2.67 Million
Q4 2023

Feb 14, 2024
SELL
$69.51 - $104.43 $103,917 - $156,122
-1,495 Reduced 3.95%
36,314 $3.61 Million
Q3 2023

Nov 13, 2023
SELL
$96.41 - $126.61 $2.99 Million - $3.93 Million
-31,053 Reduced 45.09%
37,809 $3.91 Million
Q2 2023

Aug 14, 2023
BUY
$118.5 - $160.53 $149,547 - $202,588
1,262 Added 1.87%
68,862 $8.37 Million
Q1 2023

May 15, 2023
BUY
$135.66 - $197.02 $399,518 - $580,223
2,945 Added 4.55%
67,600 $10.4 Million
Q4 2022

Feb 08, 2023
BUY
$118.38 - $210.04 $1.39 Million - $2.47 Million
11,773 Added 22.26%
64,655 $11.6 Million
Q3 2022

Nov 15, 2022
BUY
$118.07 - $194.18 $2.39 Million - $3.94 Million
20,278 Added 62.19%
52,882 $6.25 Million
Q2 2022

Aug 10, 2022
BUY
$117.13 - $176.59 $423,776 - $638,902
3,618 Added 12.48%
32,604 $4.66 Million
Q1 2022

May 10, 2022
BUY
$126.46 - $235.05 $1.51 Million - $2.8 Million
11,905 Added 69.7%
28,986 $4.99 Million
Q4 2021

Feb 04, 2022
BUY
$225.82 - $368.51 $271,887 - $443,686
1,204 Added 7.58%
17,081 $4.34 Million
Q3 2021

Nov 10, 2021
BUY
$221.9 - $484.47 $2.07 Million - $4.52 Million
9,337 Added 142.77%
15,877 $6.11 Million
Q2 2021

Aug 10, 2021
BUY
$129.91 - $234.98 $163,296 - $295,369
1,257 Added 23.79%
6,540 $1.54 Million
Q1 2021

May 11, 2021
SELL
$109.18 - $185.98 $39,195 - $66,766
-359 Reduced 6.36%
5,283 $692,000
Q4 2020

Feb 12, 2021
SELL
$65.74 - $169.86 $88,617 - $228,971
-1,348 Reduced 19.28%
5,642 $589,000
Q3 2020

Dec 10, 2020
BUY
$54.34 - $94.85 $143,620 - $250,688
2,643 Added 60.8%
6,990 $495,000
Q2 2020

Aug 10, 2020
BUY
$29.67 - $80.0 $128,975 - $347,760
4,347 New
4,347 $279,000

Others Institutions Holding MRNA

# of Institutions
857
Shares Held
266M
Call Options Held
28.5M
Put Options Held
34.9M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.74B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email